HOOKIPA Pharma to Participate in Upcoming Investor Conferences in May

Rhea-AI Summary

HOOKIPA Pharma Inc. (NASDAQ: HOOK) announced its participation in several investor conferences in May 2022. Key events include the BofA Securities 2022 Healthcare Conference from May 10-13, with a fireside chat on May 10 at 8:40am PT; the 2022 RBC Capital Markets Global Healthcare Conference on May 17-18, featuring a chat on May 17 at 4:05pm ET; and the H.C. Wainwright Global Investment Conference from May 23-26, with a chat on May 24 at 2:00pm ET. Webcasts will be available on their website, with archived replays accessible for 30 days.

NEW YORK and VIENNA, Austria, May 03, 2022 (GLOBE NEWSWIRE) -- New York, US and Vienna, Austria, May 2, 2022 - HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, today announced that HOOKIPA’s management team will participate in and present at the following upcoming investor conferences:

• BofA Securities 2022 Healthcare Conference, May 10-13, Las Vegas 
  Fireside Chat: May 10, 8:40am PT

• 2022 RBC Capital Markets Global Healthcare Conference, May 17-18, New York
  Fireside Chat: May 17, 4:05pm ET
  

• H.C. Wainwright Global Investment Conference, May 23-26, Miami Beach
  Fireside Chat: May 24, 2:00pm ET
  

Webcasts will be available within the Investors & Media section of HOOKIPA’s website at https://ir.hookipapharma.com/events. Archived replays will be accessible for 30 days following each event.

About HOOKIPA
HOOKIPA Pharma Inc. (NASDAQ: HOOK) is a clinical-stage biopharmaceutical company focused on developing novel immunotherapies, based on its proprietary arenavirus platform, that are designed to mobilize and amplify targeted T cells and thereby fight or prevent serious disease. HOOKIPA’s replicating and non-replicating technologies are engineered to induce robust and durable antigen-specific CD8+ T cell responses and pathogen-neutralizing antibodies. HOOKIPA’s pipeline includes wholly-owned investigational arenaviral immunotherapeutics targeting HPV16+ cancers, prostate cancer, KRAS-mutated cancers (including colorectal, pancreatic and lung), and other undisclosed programs. In addition, HOOKIPA aims to develop functional cures of HBV and HIV in collaboration with Gilead.

Find out more about HOOKIPA online at www.hookipapharma.com.

For further information, please contact:                                         

Media	Investors
Instinctif Partners	Matt Beck
hookipa@instinctif.com	Executive Director – Investor Relations
+44 (0)20 7457 2020	matthew.beck@hookipapharma.com

FAQ

What investor conferences will HOOKIPA Pharma participate in May 2022?

HOOKIPA Pharma will participate in the BofA Securities 2022 Healthcare Conference, the RBC Capital Markets Global Healthcare Conference, and the H.C. Wainwright Global Investment Conference.

When is HOOKIPA's fireside chat at the BofA Securities Healthcare Conference?

The fireside chat at the BofA Securities Healthcare Conference is scheduled for May 10, 2022, at 8:40am PT.

What date is HOOKIPA's presentation at the RBC Capital Markets Healthcare Conference?

HOOKIPA's fireside chat at the RBC Capital Markets Global Healthcare Conference is on May 17, 2022, at 4:05pm ET.

When will HOOKIPA present at the H.C. Wainwright Global Investment Conference?

HOOKIPA's fireside chat at the H.C. Wainwright Global Investment Conference will take place on May 24, 2022, at 2:00pm ET.

Where can I access HOOKIPA Pharma's conference webcasts?

Webcasts of HOOKIPA's conference presentations can be accessed within the Investors & Media section of their website.